Type:

Measuring water loss from the skin can predict anaphylaxis during food challenges 13th November 2023

New research finds that measuring water loss through the skin during food challenges can predict anaphylaxis before symptoms appear, increasing patient comfort and safety.

Read more
New study shows sublingual immunotherapy is effective in young children with peanut allergy 10th November 2023

Researches in the US have completed a trial examining the safety and efficacy of sublingual immunotherapy and found it has potential for long lasting effects and is most effective in young children.

Read more
DBV Technologies to start supplemental safety trial for peanut allergy skin patch 10th November 2023

The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.

Read more
Employee wins law suit after being dismissed for taking time off to recover from anaphylaxis 9th November 2023

An employee who was sacked after taking five days off work to recover from a near-fatal allergic reaction has successfully sued his employer on the grounds of disability discrimination.

Read more
Pharmacist saves woman having a near-fatal allergic reaction to bee sting in Northern Ireland 8th November 2023

A community pharmacist in Co Down, Northern Ireland, has been celebrated as a local hero after treating a woman with adrenaline after a bee sting caused an anaphylactic reaction

Read more
The FAIR Study – opportunity for healthcare professionals to take part 2nd November 2023

Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.

Read more
Over half of takeaways surveyed in Newry, Northern Ireland, failed dairy free allergen test 1st November 2023

A survey by Newry Council has found that 37 out of 63 takeaway meals sampled failed a test for the presence of milk.

Read more
Cancer drug acalabrutinib shown to temporarily prevent allergic reactions to peanuts 1st November 2023

A small study has shown that a cancer drug called acalabrutinib improves tolerance to peanuts in the short term, making it the first drug to achieve rapid-onset prevention of IgE-induced food reactivity.

Read more
Things to remember on the 5th of November 26th October 2023

Enjoy the celebrations of Bonfire Night with our tips for staying safe if you have a food allergy.

Read more